Intended for healthcare professionals

Letters Cancer mortality during covid-19

Distinguishing between direct and indirect consequences of covid-19

BMJ 2020; 369 doi: (Published 15 June 2020) Cite this as: BMJ 2020;369:m2377
  1. Jonine D Figueroa, epidemiologist,
  2. Paul M Brennan, clinical lecturer and honorary specialist registrar in neurosurgery,
  3. Evropi Theodoratou, professor and personal chair of cancer epidemiology and global health,
  4. Michael T C Poon, neurosurgical trainee and Cancer Research UK clinical fellow,
  5. Karin Purshouse, clinical lecturer in medical oncology,
  6. Farhat V N Din, CRUK clinician scientist,
  7. Kai Jin, doctor and data scientist,
  8. Ines Mesa-Eguiagaray, doctoral fellow,
  9. Malcolm G Dunlop, professor of coloproctology and consultant colorectal surgeon,
  10. Peter S Hall, reader in cancer informatics and health economics,
  11. David Cameron, professor of medical oncology,
  12. Sarah H Wild, professor of epidemiology,
  13. Cathie L M Sudlow, personal chair of neurology and clinical epidemiology
  1. University of Edinburgh, Edinburgh, UK
  1. jonine.figueroa{at}

Analysing trends in cause specific excess deaths provides useful information on the consequences of the covid-19 pandemic. Lai and colleagues call for real time weekly data on cause specific mortality as these data are currently delayed in England, Wales, and Northern Ireland.12 In England, over 25% of all deaths are registered more than one week after death, and around 10% registered more than two weeks …

View Full Text

Log in

Log in through your institution


* For online subscription